#7. FDA Roadmap: Reducing Animal Testing in Preclinical Studies (04/22/2025)
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
#7. FDA Roadmap: Reducing Animal Testing in Preclinical Studies (04/22/2025)
-
Lu par :
-
De :
À propos de cette écoute
This podcast, a roadmap from the FDA, features a strategy to decrease animal testing in preclinical safety studies by increasing the use of New Approach Methodologies (NAMs) like organ-on-a-chip systems and computer modeling. The roadmap acknowledges the limitations of animal models in predicting human responses and highlights scientific, ethical, and economic drivers for this shift. It proposes a phased implementation, starting with monoclonal antibodies, and emphasizes interagency collaboration, particularly through ICCVAM, to validate and adopt these novel methods. The FDA aims to develop clear regulatory guidance, incentivize the use of NAMs, and establish a long-term vision where animal testing becomes the exception rather than the rule, ultimately improving drug development and public health. Produced by Dr. Jake Chen.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
